首页|期刊导航|中华医学杂志（英文版）|γδT cells:Major advances in basic and clinical research in tumor immunotherapy

γδT cells:Major advances in basic and clinical research in tumor immunotherapy

Yueqi Zhao Peng Dong Wei He Jianmin Zhang Hui Chen

中华医学杂志（英文版）2024，Vol.137Issue(1)：21-33,13.

中华医学杂志（英文版）2024，Vol.137Issue(1)：21-33,13.DOI:10.1097/CM9.0000000000002781

γδT cells:Major advances in basic and clinical research in tumor immunotherapy

Yueqi Zhao ¹Peng Dong ²Wei He ¹Jianmin Zhang ³Hui Chen³

作者信息

1. Department of Immunology,CAMS Key Laboratory for T Cell and Immunotherapy,State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences and School of Basic Medicine,Peking Union Medical College,Beijing 100005,China
2. Changzhou Xitaihu Institute for Frontier Technology of Cell Therapy,Changzhou,Jiangsu 213000,China
3. Department of Immunology,CAMS Key Laboratory for T Cell and Immunotherapy,State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences and School of Basic Medicine,Peking Union Medical College,Beijing 100005,China||Changzhou Xitaihu Institute for Frontier Technology of Cell Therapy,Changzhou,Jiangsu 213000,China||Haihe Laboratory of Cell Ecosystem,Chinese Academy of Medical Sciences and Peking Union Medical College,Tianjin 300020,China
折叠

摘要

关键词

Gamma-delta T-cells/T cell receptor/CD1a/Tumor immunotherapy/Receptors,chimeric antigen/Vδ1 cells/αβ T cells

Key words

Gamma-delta T-cells/T cell receptor/CD1a/Tumor immunotherapy/Receptors,chimeric antigen/Vδ1 cells/αβ T cells

引用本文复制引用

Yueqi Zhao,Peng Dong,Wei He,Jianmin Zhang,Hui Chen..γδT cells:Major advances in basic and clinical research in tumor immunotherapy[J].中华医学杂志（英文版）,2024,137(1):21-33,13.

基金项目

This work was supported by grants from the National Natural Science Foundation of China(Nos.32270915,31970843,82071791,U20A20374,and 81972886),the National Key Research and Development Program of China(No.2022YFC3602004),the CAMS Initiative for Innovative Medicine(Nos.2021-I2M-1-005,2021-I2M-1-035,and 2021-I2M-1-053),Haihe Laboratory of Cell Ecosystem Innovation Fund(No.22HHXBSS00028),the CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses(No.3332020035),Changzhou Science and Technology Support Plan(No.CE20215008),and Beijing Municipal Commission of Science and Technology Fund for Innovative Drug(No.Z221100007922040). （Nos.32270915,31970843,82071791,U20A20374,and 81972886）

中华医学杂志（英文版）

OACSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航